News

The White House has scheduled a meeting for next week with a cannabis biotechnology company executive regarding a proposed enforcement policy for CBD products. The Office of Information and Regulatory Affairs (OIRA) under the White House Office of Management and Budget (OMB) announced earlier this month that it plans to review yet-unpublished guidance titled “Cannabidiol (CBD) Products Compliance and Enforcement Policy” that was submitted by the Food and Drug Administration (FDA). Interested parties are able to request meetings for discuss the issue-and now the first meeting is set for April . . .

A coalition of Ohio breweries are rallying residents to put pressure on their lawmakers to override the governor and give business until the end of the year to keep selling hemp-derived THC beverages as the legislature intended when they delivered a cannabis bill to his desk. While the House and Senate passed legislation last year to effectively ban the consumable cannabinoid market, it was sent to Gov. Mike DeWine (R) with language that would have carved out a temporary exception for hemp beverages, making it so those products could continue to be sold through the end of 2026. But when the . . .

Oklahoma’s Republican governor falsely claimed that marijuana use by teens has risen after medicalization, despite evidence to the contrary. The post Republican gov wants to end medical marijuana access appeared first on The Leaf Online.

This could shape cannabis laws in your state. The post Lawmakers Are Moving on Marijuana. Act Now. appeared first on NORML.

Louisiana senators have approved a bill to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin and ibogaine. The legislation from Sen. Patrick McMath (R) passed the Senate Health and Welfare Committee, with amendments, on Wednesday. The sponsor said he filed the measure after hearing from military veterans who “opened my eyes to this world” of psychedelics therapy that they received, helping him to realize “it was a growing movement.” The psychedelics program would be . . .

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. We no longer send these by email as we did in [ . . . ]

The Trump administration is claiming credit for ramping up deportations of immigrants who’ve been arrested that earned them a place on the U.S. Department of Homeland Security’s (DHS) “worst of the worst” list. That includes at least 77 people whose sole listed offense is marijuana possession. Although President Donald Trump has previously said he doesn’t think people should be jailed for possessing cannabis, and he’s moved to expedite the completion of a rule to federally reschedule marijuana, DHS is still doing a digital perp walk of noncitizens who were subject to deportation after being . . .

The U.S. Army will now allow recruits who have a single cannabis possession or drug paraphernalia possession conviction to enlist without a waiver. Prior to the regulation change, such convictions would have technically barred potential recruits from enlisting, but those with such convictions were often granted waivers to join the service. Previously, under the waiver program, recruits with a single conviction for cannabis or drug paraphernalia required a waiting period of up to 24 months, and a mandatory drug test at a Military Entrance Processing Station. The regulation changes do not . . .

Tennessee lawmakers are set to consider three cannabis-related bills next week, the Lynchburg Times reports. One bill, dubbed the Pot for Potholes Act, would legalize cannabis for adult use in the state and direct 75% of the revenues to the state highway fund. The Pot for Potholes Act would send 20% of cannabis-derived revenues to counties, with the remaining 5% earmarked for administrative costs related to regulating the cannabis industry. According to the Times, Tennessee has a $58 billion backlog in unfunded road projects, with traffic congestion costing residents an estimated $420 . . .

Tulsa Community College (TCC) has launched new cannabis certificate programs in partnership with cannabis education company Green Flower, KTUL reports. Dr. Pete Selden, TCC vice president for workforce development, told KTUL that the programs will help students “Learn about the policies around cannabis, plant science, more about the industry and compliance” and will give students “the ability to get into an entry-level job . . . starting at $20 an hour and then going up from there.” “Employer-informed programs that are online, virtual for students that desire to get into the cannabis industry to . . .

The Minority Cannabis Academy (MCA) is launching applications for its 5th cohort of students for those interested in practical NJ cannabis workforce education. They seek to provide NJ cannabis workforce development and technical assistance for underserved communities. Their program is designed to move students into sustainable, high-impact careers through technical mastery and elite networking opportunities. [ . . . ] Source: Minority Cannabis Academy Launches Applications for NJ Cannabis Workforce Education from Heady NJ

Monterey County town Pacific Grove has delayed a lottery drawing to award a dispensary license, following complaints that eight of the ten extant applications are from retailer Off The Charts. Of the ten applicants, nine were submitted for a single location on Forest Ave. The other application is for the building next door. Soon after the October application deadline, the owner of the other address wrote to the city saying that eight of the nine applications “appear to originate from one principal applicant” using separate legal entities. It requested that the city investigate the alleged . . .

A Delaware House committee has unanimously approved a Senate-passed bill that would allow terminally ill patients to use medical cannabis in hospitals. About two weeks after the legislation from Sen. Marie Pinkney (D) advanced through the Senate, members of the House Health & Human Development Committee cleared it in a 9-0 vote on Wednesday. There was limited public testimony on the measure, which is being carried in the House by Rep. Kamela Smith (D). A representative of the Delaware Healthcare Association spoke in favor of the bill’s intent, while specifically applauding revisions made in . . .

Beckley Retreats are guided by a multidisciplinary team of facilitators whose backgrounds span psychotherapy, medicine, the arts, and contemplative traditions. The retreats are hosted in thoughtfully chosen locations in Jamaica and the Netherlands. As part of the Beckley ecosystem, which builds on the pioneering work of its co-founder, Amanda Feilding. Dubbed the “Queen of Psychedelics” by author Amanda Siebert, Fielding founded the Beckley Foundation in 1998-a think tank and NGO dedicated to furthering psychedelic research and advocating for policy reform. At Beckley Retreats, the goal is to . . .

Arizona House lawmakers have approved a Senate-passed bill to penalize people who create “excessive” amounts of marijuana smoke or odor-a policy that’s faced criticism from advocates who say the proposal amounts to overreach that undermines the legalization law voters enacted. The legislation from Sen. J.D. Mesnard (R), which cleared the Senate earlier this month after being significantly amended, advanced through the House Judiciary Committee in a 8-1 vote on Wednesday. Members took public testimony on the proposal, with advocates representing organizations such as Arizona NORML and the ACLU . . .

Table of Contents Why Co‑Development Is on Pharma’s Radar Now Three Regulatory Worlds, One Cannabinoid Program Deal Architecture: Picking the Right Co‑Development Model From State Compliance to GMP Reality Building Trial‑Ready Products and Data Flows Messaging Firewalls: Keeping Drug Development and Retail Separate Contracting the Tech, the Data, and the Risk Who Owns the FDA Conversation? Patterns You Want-and Patterns You Don’t First Steps: A Pilot, a Gap Assessment, and a Plan Why Co‑Development Is on Pharma’s Radar Now Over the last several years, cannabinoid‑based products have moved . . .

Table of Contents Why Co‑Development Is on Pharma’s Radar Now Three Regulatory Worlds, One Cannabinoid Therapeutics Program Deal Architecture: Picking the Right Co‑Development Model From State Compliance to GMP Reality Building Trial‑Ready Products and Data Flows Messaging Firewalls: Keeping Drug Development and Retail Separate Contracting the Tech, the Data, and the Risk Who Owns the FDA Conversation? Patterns You Want-and Patterns You Don’t First Steps: A Pilot, a Gap Assessment, and a Plan Cannabinoid therapeutics science is finally growing up, and the rules around it are slowly catching . . .

California Gov. Gavin Newsom (D) might have helped lead the push to legalize marijuana in the state-but that advocacy didn’t exactly come from a place of extensive personal experience. In fact, beside a “complicated” trip to the Grand Canyon involving cannabis, Newsom’s THC teetotaling was so “rigid” in his youth that even his father poked fun at him. During an interview with Politico, and in a recent memoir he’s been promoting, the governor recognized that he became a somewhat unlikely champion of marijuana reform given his nearly lifelong abstinence. But when he considered the harms and . . .

Local officials in King County, Washington have approved a resolution calling on police to make enforcement of laws against possession and personal cultivation of psychedelics among the “lowest” priorities and requesting that they not use funds to arrest or prosecute people for using substances such as psilocybin mushrooms, ayahuasca, mescaline and ibogaine. The Metropolitan King County Council on Tuesday voted 6-2 to pass the legislation requesting that “investigation, arrest, and prosecution of any persons twenty-one years old or older engaging in the limited, noncommercial cultivation and . . .

The cannabis industry is in the midst of a worldwide revolution and is continuing to evolve from a patchwork of individual, siloed markets to an increasingly connected international web. That was already true, to a degree, before 2020. However, in late 2020, the United Nations Commission on Narcotic Drugs (CND) voted to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs. It was a major milestone, with the CND finally recognizing the medicinal and therapeutic benefits of cannabis. More countries are allowing medical cannabis products to be imported and exported . . .

Cannabis sits at a crossroads of mood, sensation, and sexual wellness. For some men, it may ease stress, increase body awareness, and increase intimacy. There are specific cannabis strains that act as an aphrodisiac to hep get into the mood. But for some, depending on the strain and type of consumption, it may lower motivation, [ . . . ] Source: How Cannabis Consumption Influences Male Sexual Confidence and Performance from Heady NJ

U.S. Reps. Troy Carter (D-LA) and Guy Reschenthaler (R-PA) this week introduced the bipartisan Capital Lending and Investment for Marijuana Businesses (CLIMB) Act, which aims to give state-legal cannabis companies access to the lending and investment opportunities available to other industries. Most financial institutions are currently unwilling to serve the industry, as cannabis remains a federally prohibited, Schedule I substance. But the CLIMB Act would establish protections for private lenders to provide loans and for government agencies, like the Small Business Administration (SBA), or . . .

The Georgia General Assembly has approved major updates to the state’s limited medical cannabis program, sending the proposal to Gov. Brian Kemp (R) for his consideration, the Capitol Beat News Service reports. The House voted 144-21 on Monday to give final approval to Senate Bill 220. The proposal would remove the program’s current THC caps on cannabis products, replacing the term “low THC oil” with the term “medical cannabis” in state law. The bill also adds lupus as a new qualifying condition for the program and adds vaping as an approved consumption method for cannabis patients aged 21 or . . .

“The integration of certain therapeutic cannabis products into the Medicare program further legitimizes the use of marijuana as a medicine, particularly for improving the health-related quality of life of older Americans and seniors.” The post Feds Provides Details on Plan to Integrate Hemp-Derived Products into Medicare Services appeared first on NORML.

Harris Sliwoski LLP attorney Jason Adelstone will be moderating a panel at the upcoming Industrial Hemp International Conference and Trade Show, in Denver, Colorado. Jason will be joined on the panel by attorney David Sergi and political consultant Kevin Lampe. Their session, “Legal Reality Check: Cannabinoids, Compliance, and Enforcement in a Shifting U.S. Landscape,” will take place this Thursday, March 26th, at 4:20 p.m. MST. The panel will focus on one of the most uncertain areas of hemp regulation: the likelihood that Congress extends current hemp-related restrictions, and the nature of . . .